Delivery Order SPE2DB20D1100-SPE2DB24FZ52A
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The order is for the delivery of LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product, with a potential value of $3,999.73 and a completion date of January 5, 2024. This order was placed under a larger indefinite delivery contract held by Amerisourcebergen...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,548.30 order is for the delivery of LINZESS 72 MCG capsules, a pharmaceutical product, to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $1,585.87 order is for the supply of LINZESS 145 MCG capsules to support military treatment programs and facilities. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999 and a performance period through December 31, 2025. This IDC serves as the primary...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $2,522.97 contract is for the supply of LINZESS 72 MCG CAPSULE UU 30S to support U.S. military treatment programs and facilities. The order does not have a set-aside designation and is part of a larger indefinite delivery contract (IDC) awarded solely to...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $1,406.72 contract is for the supply of LINZESS 145MCG 30S, a pharmaceutical product, in support of military treatment programs and facilities. AmerisourceBergen Drug Corp is the prime contractor and there is no set-aside designation associated with this award. This delivery order is issued under an...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LINZESS 290 MCG CAPSULE UU 30S. The total ceiling value of this order is $10,944.15. The contract is a firm fixed price, delivery order type with an ultimate completion date of August 27, 2024. This award is not associated with any set-aside program. AmerisourceBergen, through its extensive pharmaceutical supply chain...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract, valued at $2,354.39, is for the delivery of LINZESS 145 MCG capsules. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide LINZESS 145 MCG CAPSULE UU 30S. The delivery order has a completion date of February 28, 2024 and a potential value of $5,360.48. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This delivery order is part of a larger indefinite delivery contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,668.75 firm-fixed-price contract is for the supply of 4565654630 ! LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product. The contract has an ultimate completion date of September 4, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government and holds several...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 145 mcg LINZESS capsules. The contract has a ceiling value of $1,889.28 and a period of performance ending on June 30, 2022. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FZ52ADelivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,668.50 order is for the supply of LINZESS 290 MCG CAPSULE medical products. The delivery order is part of Amerisourcebergen's existing indefinite delivery contract with DLA to provide pharmaceuticals and medical supplies to support military treatment programs and facilities. No set-aside designation was used for this award, which has a completion date of January 3, 2024. Amerisourcebergen, a leading global pharmaceutical sourcing and distribution company, has previously received numerous federal contracts from DLA and other agencies to supply a range of pharmaceutical and medical products and services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 1/2/24 |